Literature DB >> 6383274

A technically simple "non-lethal" vital staining procedure for viral plaque and cell transformation assays. Brief report.

R J Klebe, J V Harriss.   

Abstract

The widely used tetrazolium dye, MTT, has several advantages as a vital stain in the identification of viral plaques. First, since the yellow colored dye MTT stains live cells dark blue, viral plaques can be counted without removal of the phenol red containing agar overlay. Secondly, the high contrast between live and dead cells afforded by MTT permits one to readily detect small plaques at an early time after infection. Thirdly, since cells intensely stained with MTT remain viable, MTT vital staining can be used to isolate cells which are either transformed or resistant to viruses. Thus, MTT vital staining should be useful in several types of viral plaque assays.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383274     DOI: 10.1007/bf01310007

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  The effect of neutral red on plaque formation in two virus-cell systems.

Authors:  J E DARNELL; R Z LOCKART; T K SAWYER
Journal:  Virology       Date:  1958-10       Impact factor: 3.616

2.  Tetrazolium salts as stains for animal virus plaque assays.

Authors:  P D COOPER
Journal:  Virology       Date:  1959-04       Impact factor: 3.616

3.  Aromatic sulfonic acids as viral inhibitors. Structure-activity study using rhino, adeno 3, herpes simplex, and influenza viruses.

Authors:  S Akerfeldt; G Westin; T Jansson
Journal:  J Med Chem       Date:  1971-07       Impact factor: 7.446

4.  Rapid cloning of mammalian cells with honeycomb cloning plates and nonlethal vital stains.

Authors:  R J Klebe
Journal:  In Vitro       Date:  1984-02

5.  Inactivation of measles and herpes simplex viruses by trypan blue.

Authors:  H V Thorne; G F Clarke
Journal:  J Gen Virol       Date:  1983-06       Impact factor: 3.891

6.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  6 in total
  8 in total

1.  Fowlpox virus polypeptides: sequential appearance and virion associated polypeptides.

Authors:  C T Prideaux; D B Boyle
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.

Authors:  K J Wiegers; K Wetz; R Dernick
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Viral concentration determination through plaque assays: using traditional and novel overlay systems.

Authors:  Alan Baer; Kylene Kehn-Hall
Journal:  J Vis Exp       Date:  2014-11-04       Impact factor: 1.355

4.  Genomic RNA of an insect virus directs synthesis of infectious virions in plants.

Authors:  B H Selling; R F Allison; P Kaesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  Infectious laryngotracheitis virus growth, DNA replication, and protein synthesis.

Authors:  C T Prideaux; K Kongsuwan; M A Johnson; M Sheppard; K J Fahey
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.

Authors:  S B Sobottka; M R Berger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.

Authors:  Rebecca Lamb; Gloria Bonuccelli; Béla Ozsvári; Maria Peiris-Pagès; Marco Fiorillo; Duncan L Smith; Generoso Bevilacqua; Chiara Maria Mazzanti; Liam A McDonnell; Antonio Giuseppe Naccarato; Maybo Chiu; Luke Wynne; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2015-10-13

8.  Pathophysiology of Influenza D Virus Infection in Specific-Pathogen-Free Lambs with or without Prior Mycoplasma ovipneumoniae Exposure.

Authors:  Ema Robinson; Clyde Schulein; B Tegner Jacobson; Kerri Jones; Jonathon Sago; Victor Huber; Mark Jutila; Diane Bimczok; Agnieszka Rynda-Apple
Journal:  Viruses       Date:  2022-06-28       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.